New therapy for human dwarfism

21 Jun 2019


Vosoritide, a recombinant C-type natriuretic peptide analogue, has shown promise in treating children with achondroplasia, according to data published in the New England Journal of Medicine.

Medscape


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story